Clinical Trial Update: Effects of ELAVl and CDOA vs Upper Thoracic Mobilization on Forward Head Posture in Upper Cross Syndrome [NA]

View source ↗

Summary

The clinical trial NCT06739889 evaluates ELAVl and CDOA against Upper Thoracic Mobilization for forward head posture in individuals with Upper Crossed Syndrome;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Crossed Syndrome

Drugs mentioned

• CDOA
• ELAVl

Snippet

Sponsor: Superior University | Conditions: Cross Syndrome | NA | Status: ACTIVE_NOT_RECRUITING